MDLRX
Price
$25.52
Change
-$0.18 (-0.70%)
Updated
Jul 13 closing price
Net Assets
3.94B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MDLRX vs VSTSX

MDLRX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MDLRX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDLRX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. MDLRX (3.94B). VSTSX pays higher dividends than MDLRX: VSTSX (1.07) vs MDLRX (0.36). MDLRX was incepted earlier than VSTSX: MDLRX (27 years) vs VSTSX (10 years). MDLRX (0.86) is less costly to investors than VSTSX (0.01). MDLRX is a more actively managed with annual turnover of: 117.00 vs. VSTSX (3.00). MDLRX has a lower initial minimum investment than VSTSX: MDLRX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. MDLRX (17.87). VSTSX return over 5 years is better than : 66.56 vs. MDLRX (17.55).
MDLRXVSTSXMDLRX / VSTSX
Total Expense Ratio0.730.017,300%
Annual Report Gross Expense Ratio0.860.018,600%
Fund Existence27 years10 years-
Gain YTD13.91811.205124%
Front Load5%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B2.3T0%
Annual Yield % from dividends0.361.0734%
Returns for 1 year17.8721.4883%
Returns for 3 years46.7967.0670%
Returns for 5 years17.5566.5626%
Returns for 10 years56.02239.5323%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I